BMY - Bristol-Myers Squibb Co
This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2017 it was held by 7 managers with an aggregate reported value of $1.68B, which is 0.21% of the combined portfolio.
As of Q2 2017, 7 tracked institutional managers held BMY (Bristol-Myers Squibb Co) with an aggregate reported value of $1.68B — 0.21% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BMY — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2017
- Ticker
- BMY
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 1.39% | Add +1.6% | 29,579,461 | $1.65B |
| 2 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.23% | Reduce -0.4% | 343,043 | $19.11M |
| 3 | Muhlenkamp - Muhlenkamp | 3.25% | Reduce -0.1% | 177,974 | $9.92M |
| 4 | Jensen Investment Management - Jensen Investment Management | 0.03% | - | 33,000 | $1.84M |
| 5 | Kahn Brothers Group - Kahn Brothers Group | 0.17% | Reduce -31.5% | 19,583 | $1.09M |
| 6 | First Eagle - First Eagle Investment Management | 0.00% | Reduce -1.7% | 11,329 | $631K |
| 7 | Thomas Gayner - Markel Asset Management | 0.01% | - | 10,000 | $557K |
Loading holder history for BMY…